Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$441M |
| 2 |
Broadcom
AVGO
|
+$328M |
| 3 |
Pfizer
PFE
|
+$292M |
| 4 |
Tesla
TSLA
|
+$252M |
| 5 |
IBM
IBM
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$295M |
| 2 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$138M |
| 3 |
General Mills
GIS
|
+$131M |
| 4 |
Chevron
CVX
|
+$116M |
| 5 |
PPG Industries
PPG
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Financials | 13.22% |
| 3 | Healthcare | 13.19% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HLVX
2651
DELISTED
HilleVax
HLVX
| $1.57M | ﹤0.01% |
91,822
+1,157
| +1% | +$16.8K |
|
|
VIA
2652
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $1.57M | ﹤0.01% |
45,331
| – | – |
|
|
ENFN
2653
DELISTED
Enfusion, Inc.
ENFN
| $1.56M | ﹤0.01% |
126,181
-23,207
| -16% | -$283K |
|
2654
The Honest Company
HNST
$402M
| $1.55M | ﹤0.01% |
441,429
+184,105
| +72% | +$676K |
|
2655
UFP Technologies
UFPT
$1.97B
| $1.54M | ﹤0.01% |
17,968
+27
| +0.2% | +$2.37K |
|
2656
Rush Street Interactive
RSI
$2.77B
| $1.54M | ﹤0.01% |
418,862
+13,527
| +3% | +$71.5K |
|
2657
KRONOS Worldwide
KRO
$693M
| $1.52M | ﹤0.01% |
163,254
+4,948
| +3% | +$72.5K |
|
2658
Entravision Communication
EVC
$1.03B
| $1.52M | ﹤0.01% |
382,078
+52
| +0% | +$257 |
|
2659
Holley
HLLY
$321M
| $1.51M | ﹤0.01% |
373,960
+77,977
| +26% | +$583K |
|
2660
Harrow
HROW
$1.45B
| $1.51M | ﹤0.01% |
124,962
| – | – |
|
2661
Viridian Therapeutics
VRDN
$2.09B
| $1.51M | ﹤0.01% |
73,549
+5,303
| +8% | +$95.3K |
|
2662
GeneDx Holdings
WGS
$1.93B
| $1.51M | ﹤0.01% |
51,974
+2,300
| +5% | +$105K |
|
2663
GrowGeneration
GRWG
$86.5M
| $1.5M | ﹤0.01% |
429,911
+38,464
| +10% | +$178K |
|
2664
Stagwell
STGW
$2.07B
| $1.5M | ﹤0.01% |
215,889
+13,595
| +7% | +$87.8K |
|
|
CTIC
2665
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $1.5M | ﹤0.01% |
257,696
+16,684
| +7% | +$104K |
|
|
CYXT
2666
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
| $1.5M | ﹤0.01% |
366,602
+97,408
| +36% | +$858K |
|
2667
MaxCyte
MXCT
$112M
| $1.5M | ﹤0.01% |
229,969
+38,797
| +20% | +$216K |
|
2668
Century Therapeutics
IPSC
$364M
| $1.49M | ﹤0.01% |
150,347
+55,616
| +59% | +$586K |
|
|
PNT
2669
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $1.49M | ﹤0.01% |
192,230
+441
| +0.2% | +$3.74K |
|
2670
Atlassian
TEAM
$25.6B
| $1.48M | ﹤0.01% |
7,016
+864
| +14% | +$202K |
|
2671
Forestar Group
FOR
$1.44B
| $1.48M | ﹤0.01% |
131,863
+3,370
| +3% | +$44.6K |
|
2672
United States Lime & Minerals
USLM
$3.16B
| $1.47M | ﹤0.01% |
72,070
-1,850
| -3% | -$39.3K |
|
|
ORGN
2673
DELISTED
Origin Materials
ORGN
| $1.47M | ﹤0.01% |
9,503
+174
| +2% | +$30.8K |
|
2674
BlueLinx
BXC
$422M
| $1.47M | ﹤0.01% |
23,638
-789
| -3% | -$56.9K |
|
|
EGLE
2675
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $1.47M | ﹤0.01% |
33,915
-883
| -3% | -$41.8K |
|
Similar funds
Charles Schwab's Q3 2022 Portfolio in Review
As of Q3 2022, Charles Schwab held 3,614 positions worth $279B, down 2.9% from $287B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab deployed $8.77B of net new capital in Q3 2022, opening 79 new positions and adding to 2,461 existing holdings. Its largest new stake was JPMorgan Ultra-Short Income ETF: 2,974,316 shares worth $149M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $295M trimmed.
- Charles Schwab's largest Q3 2022 buy was JPMorgan Ultra-Short Income ETF: 2,974,316 shares worth $149M.
- Charles Schwab added most to Verizon in Q3 2022, an estimated $441M increase.
- Charles Schwab's biggest Q3 2022 reduction was iShares National Muni Bond ETF, cutting an estimated $295M.
- Charles Schwab fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $91.4M.
- Charles Schwab's ten largest holdings make up 17% of its $279B portfolio in Q3 2022.
- Charles Schwab opened 79 new positions and closed 105 in Q3 2022.
- Charles Schwab's portfolio value fell 2.9% quarter-over-quarter to $279B.
Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.